Open AccessYellow Fever Vaccination of Human Immunodeficiency Virus-Infected Patients: Report of 2 Cases
Author(s) -
M. C. Receveur,
Rodolphe Thiébaut,
S. Védy,
Denis Malvy,
P. Mercié,
M. Le Bras
Publication year - 2000
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/314031
Subject(s) - medicine , immunosuppression , yellow fever , virology , vaccination , yellow fever vaccine , human immunodeficiency virus (hiv) , virus , attenuated vaccine , immunology , viral disease , biology , virulence , biochemistry , gene
Yellow fever vaccine (17D, a live attenuated virus vaccine) was effective and safe in 2 human immunodeficiency virus-infected patients without severe immunosuppression, one of whom traveled to Kenya and the other of whom traveled to Senegal.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom